INTRODUCTION
In human serum, 70% of thyroid hormones is bound to thyroxine-binding globulin (TBG), a 54-kDa glycoprotein of hepatic origin (1, 2) . Biochemical interest in TBG stems mainly from its exceptionally high binding affinity for T 4 [association constant (K a ) ϭ 10 10 M Ϫ1 ] and T 3 (K a ϭ 10 9 M Ϫ1 ) (3) . In contrast to the other T 4 -binding proteins, transthyretin and albumin, its ligand interaction is undefined at a molecular level as attempts to crystallize TBG have failed (4) , probably due to its microheterogenic glycosylation (5) .
TBG belongs to the superfamily of serine-proteinase inhibitors (serpins) (6) , a functionally heterogeneous group of more than 100 proteins, including ␣ 1 -proteinase inhibitor (␣ 1 PI), ␣ 1 -antichymotrypsin, and corticosteroid-binding globulin (CBG). TBG and CBG are the only serpins with a transport function for small hydrophobic ligands. The crystallographic structures of several serpins have been determined and were found to be highly conserved (reviewed in Refs. 7 and 8) . The structure of the archetypal ␣ 1 PI consists of three large ␤-sheets (A-C) and eight well defined helices (9) . This structure model has been successfully used as template for structure-function correlations of other serpins (7) , including the heat-resistant TBG-Chicago variant (10) . Since natural variants with binding defects invariably also have low expression levels and increased serum concentrations of the denatured molecule, the correlation of their mutations with the structure model has been of limited value (reviewed in Refs. 11 and 12) .
Binding studies of T 4 analogs support the notion that all parts of the molecule participate in its avid binding to TBG (13) . Considering the high binding affinity, T 4 would seem to bind deep in a binding pocket, similar to T 4 binding to transthyretin (14) rather than binding to the flat pocket in albumin (15) . In analogy to the ligand-binding site of transthyretin, a barrel of ␤-strands, formed by sheets B and C, has been proposed as the binding domain of TBG (16) . This is supported by affinity cross-linking of Lys 253 (17) , which maps to the binding cavity. The ␤-barrel of TBG has also recently been transferred to the ␣ 1 PI scaffold, generating a T 4 -binding chimera, confirming that this structural domain encompasses the ligandbinding site (18) . A region corresponding to strands 2B and 3B of the eight-stranded ␤-barrel is highly conserved when compared with TBG from sheep (19) and rat (20) (Fig. 1) , all of which have the same high T 4 -binding affinity (21) . In this paper, we present a characterization of this phylogenetically conserved region by site-directed mutagenesis.
RESULTS

Design of TBG Mutations
TBG from sheep (19) and rat (20) share 82% and 76% of their amino acid sequence with human TBG, respectively. However, within the putative ligand-binding domain, a stretch of 26 residues (Val 228 -Lys 253 ) is almost completely conserved in all known TBG sequences. This region corresponds to two antiparallel ␤-strands, 2B and 3B, of the ␤-barrel motif of ␣ 1 PI. Comparison of TBG with other serpins reveals several distinct differences (Fig. 1) . At the entrance to the ␤-barrel, the Thr 235 of TBG corresponds to the bulkier Trp 238 in ␣ 1 PI. This substitution has been speculated to block the access to the ␤-barrel in ␣ 1 PI (7, 22, 23) , which has no known ligand. To test this hypothesis, Thr 235 of TBG was substituted by a tryptophan (TBGmB). This mutation destroys the glycosylation site 233-235, which is unique to and conserved in all known TBG sequences. The corresponding glycosylation site of other serpins is located at residues 247-249 (␣ 1 PI numbering) and lies at the opposite end of the ␤-barrel. Mutation mA (Cys 234 3Trp) introduces a tryptophan at the entrance to the ␤-barrel but keeps the glycosylation site 233-235 intact. Mutation mC (Thr 235 3Gln) destroys the glycosylation site, but the small glutamine should not block access to the ␤-barrel. Mutation mD (Leu 246 3Thr) generates an intact glycosylation site at 244-246, corresponding to the highly conserved glycosylation site of other serpins. Compared with normal TBG (TBG-N), mutant mD thus has an additional glycosylation site. Access to the ␤-barrel could also be dependent on the mobility of the involved ␤-strands. In ␣ 1 PI, ␣ 1 -antichymotrypsin, and several other serpins, but not in TBG, the ␤-strands 2B and 3B are held together by a salt bridge. Substitution of Val 228 by glutamic acid (mG) allows the formation of a salt bridge between residues 228 and 253 of TBG and thus might impede T 4 binding. Binding studies with T 4 analogs (13) suggest that interactions of the negatively charged oxygen and carboxy groups and the positively charged amino group of the T 4 molecule are important for the high-affinity binding. An attractive candidate for electrostatic interactions is the positively charged Lys 253 , which has been shown to be near the ligand-binding domain by affinity labeling (17) and lies at the entrance of the ␤-barrel. Lys 253 was substituted with the negatively charged aspartic acid (mE) and the neutral alanine (mH) to test whether electrostatic interactions at this position play a role in T 4 -binding. However, interactions within the binding cavity would appear to be more important than those with the entrance of the ␤-barrel. It has been speculated (22) that the iodines of T 4 could interact with aromatic residues, comparable to mercury-iodide binding to sperm whale myoglobin (24) . To test this The sequence between V 228 and E 254 of TBG is phylogenetically highly conserved. The only mismatches are at position 230 and 243. In the ␣ 1 PI structure model this region forms strands 2B and 3B, which contribute to the ␤-barrel motif. Note that TBG has an Asn-linked glycosylation consensus site at the beginning of s2B (boxed), whereas in other serpins a glycosylation site is found near the turn between s2B and s3B and thus at the opposite side of the ␤-barrel. hTBG, Human TBG; rTBG, rat TBG; sTBG, sheep TBG; ACh, ␣ 1 -antichymotrypsin.
hypothesis, phenylalanines thought to contribute to the aromatic interior of the binding cavity were individually substituted by alanine (mutations mF249, mF284, mF288, mF371, and mF315). All mutants were constructed by site-directed mutagenesis and verified by dideoxy sequencing as described in Materials and Methods.
Expression of Normal and Mutant TBG in Reticulocyte Lysate
The linearized vectors for TBG-N and the mutants were transcribed in vitro and translated in reticulocyte lysate. All mutants were synthesized with comparable efficiency and had identical patterns of nonglycosylated forms on SDS-PAGE (data not shown). After addition of canine microsomal membranes to the translation reactions, all variants had a major band at 44 kDa, which corresponded to unglycosylated TBG after signal peptide processing, and several new bands of higher mol wt, which reflected the number of available N-glycosylation sites (Fig. 2 ). As expected, mutants mB and mC had one less glycosylation site and mutant mD had an additional glycosylation site when compared with TBG-N. The phenylalanine mutations were not expressed in the reticulocyte lysate system, since no effect on glycosylation was expected.
Expression of Normal and Mutant TBG in Xenopus Oocytes
Oocytes were removed from Xenopus laevis, culled, injected with TBG synthetic messenger RNA (sRNAs), and incubated in medium with [ 35 S]methionine. The TBG mutants synthesized and secreted into the medium were then submitted to SDS-PAGE (Fig. 3) . The broad appearance of the bands is due to the microheterogenic glycosylation, which is faithfully reproduced in the Xenopus system. In addition, variants mB-mH differed by size depending on the number of glycosylation sites. However, no significant differences of the amount of secreted protein could be observed when compared with TBG-N except for mutant mA, which was not produced by the oocytes in several experiments (Fig. 3A) . Of the phenylalanine mutants, mF284-mF371 were synthesized by the oocytes in the same amount as TBG-N (data not shown). TBG mF249 was also expressed with a mol wt equal to TBG-N, but in slightly lower amounts (Fig. 3B) .
Analysis of T 4 Binding to TBG
The amount of functionally active TBG synthesized in Xenopus oocytes was examined by measurement of the T 4 binding characteristics. The TBG mutants were expressed as described above, but without the addi-
Fig. 2. Synthesis of Normal and Mutant TBG in Reticulocyte Lysate
In vitro transcribed RNA of the TBG mutants was translated in rabbit reticulocyte lysate. In the presence of canine microsomal membranes (CMM), all variants showed a major band (44 kDa) corresponding to unglycosylated TBG with a processed signal peptide. The number of the slower migrating bands reflects the number of N-glycosylation sites available for core glycosylation within the microsomes. Note the introduction of an additional glycosylation site in mutant mD, the deletion of a glycosylation site in mutants mB and mC, and the detrimental effect of mutant mA on the amount of the completely glycosylated product. MWM, Mol wt marker (69K, 46K).
Fig. 3. SDS-PAGE Analysis of TBG Variants Expressed in Xenopus Oocytes
Oocytes injected with sRNAs were incubated in the presence of [ 35 S]methionine. A, The mutants mB-mH differed by size depending on the number of glycosylation sites. While mutant mA was not secreted into the medium, no significant differences in the efficiency of synthesis and secretion of the other TBG mutants compared with TBG-N were found in four independent experiments. B, Of the Phe3Ala mutants, mF249 was secreted in slightly reduced amounts compared with TBG-N, while mF284, mF288, mF315, and mF371 differed neither in expression level nor in apparent mol wt from TBG-N (not shown). MWM:
14 C-labeled mol wt markers.
tion of [ 35 S]methionine. Scatchard analysis of the secreted TBG mutants revealed no significant differences in T 4 binding affinity and capacity/oocyte of the variants mB, mC, mG, and mH ( Fig. 4A and Table 1 ). However, the T 4 binding affinity of mD was 20 times lower than that of TBG-N. Of the phenylalanine mutations, only mF249 showed a significant reduction of binding affinity, by at least 2 orders of magnitude ( Fig.  4B and Table 1 ).
Heat Resistance of TBG Variants
To determine the functional stability of the TBG variants, heat denaturation was performed. At 58 C, no significant differences in the rate of heat denaturation of TBG-N and the variants mB, mC, mE, mG, and mH were found (Fig. 5) .
Immunoprecipitation of TBG-N and Variant mD
To test for the immunological integrity of variant mD, samples were immunoprecipitated with either a polyclonal antibody against both nTBG and dnTBG or an antibody specific for dnTBG. Both TBG-N and mD were almost exclusively recognized by anti-nTBG (Fig.  6A) . In addition, immunoprecipitation in the presence of excess nTBG or dnTBG, respectively, revealed that both TBG-N and TBG mD were competed only by nTBG, indicating that both molecules were correctly folded (Fig. 6B) .
DISCUSSION
In this paper we describe a rational approach to define the impact of individual residues of TBG on T 4 binding by site-directed mutagenesis. Previous attempts to characterize the binding site of TBG have relied on the identification of naturally occurring mutations. So far, all of the six binding-deficient variants characterized on a molecular level exhibit lower expression levels than TBG-N and more or less explicit heat lability (11, 12, 25) . Since these natural variants are also characterized by increased dnTBG serum concentrations, they most likely decrease T 4 binding by gross structural changes. Thus, the analysis of natural occurring TBG variants has failed to contribute to our understanding of the structural requirements of TBG for T 4 binding, consistent with the location of the affected residues throughout the molecule but not within the ␤-barrel.
Apart from mutant mA, all TBG mutants generated in this study were synthesized and secreted by Xenopus oocytes in similar amounts as TBG-N. The respective amino acid substitutions can thus be assumed not to interfere with the folding and processing of the molecule, because this has been found to lead to lower expression levels in all known natural mutations (26, 27) . Mutants mB, mC, mG, and mH even had a normal heat stability. The secretion defect of mA most likely results from inefficient glycosylation of the neighboring Asn 233 , as demonstrated by the reduced utilization of this glycosylation site in the cell-free translation system (Fig. 2) . This finding is compatible with a previous report on the glycosylation efficiency of N-linked core glycosylation, where glycosylation sites with Trp in the X-position of an Asn-X-Ser sequon were found to be inefficiently processed (28) .
Neither the introduction of a putative salt bridge between the ␤-strands, nor the sterical hindrance by introduction of a bulky tryptophan, nor modification of the glycosylation at the entrance to the ligand-binding site had an impact on the T 4 binding affinity. A major effect, however, was seen after introduction of a new glycosylation site at position 244 (mutant mD), a site highly conserved in other serpins (Fig. 1) . The integrity of mutant mD could not be ascertained by heat denaturation due to its low binding capacity. However, immunological studies showed that it was detected only with antibodies against nTBG and not dnTBG and could only be displaced with nTBG and not dnTBG from polyclonal antibodies (Fig. 6) . Therefore, introduction of the additional glycosylation site in mutant mD appears to cause a specific binding defect. As shown in a model of the TBG ␤-barrel (Fig. 7) , Leu (9) also reveals that the carbohydrate moiety linked to this site anchors the turn between strands 2B and 3B to helix D. Accordingly, the binding pocket in ␣ 1 PI is smaller than in ovalbumin, the only other serpin lacking glycosylation of the corresponding site (30) . Introduction of the mutation mD in TBG could thus reduce binding by diminishing the available space for T 4 . In contrast, this glycosylation site has been previously shown to be crucial and sufficient for corticosteroid binding of CBG (31) . CBG normally contains six glycosylation sites and inactivation of only the Asn 238 , which corresponds to the Asn 244 of TBG, abolished ]methionine-labeled samples were immunoprecipitated with either a polyclonal antibody that recognizes both nTBG (n) and dnTBG (dn) or an antibody that recognizes only dnTBG and then submitted to SDS-PAGE and autoradiographed. Both TBG-N and TBG mD were recognized by anti-n/dnTBG (lanes 2 and 4) but only weakly by the antidnTBG antibody (lanes 3 and 5) . B, Samples were immunoprecipitated with the anti-n/dnTBG antibody without (Ϫ) and with competition; n denotes residual nTBG from samples competed with dnTBG; dn denotes residual dnTBG from samples competed with nTBG. Both TBG-N and TBG mD were competed only by nTBG, indicating that the molecules were correctly folded. MWM, steroid binding. A mutant containing only this glycosylation site (the other five were inactivated) had normal steroid binding, which was not altered by deglycosylation of the molecule. This suggests that interaction of the polypeptide with the carbohydrate at the glycosylation site Asn 238 is necessary for the folding and creation of the steroid-binding site only during CBG biosynthesis (32) and implicates substantial differences in the structure of the ligand-binding sites of TBG and CBG.
The reduced binding of mD taken together with the lack of effect of the mutations at the putative entrance of the ␤-barrel (7) would be compatible with T 4 entering the binding cavity from the opposite side of the molecule, as proposed by Terry and Blake (22) and Jarvis et al. (23) . While the latter entrance would be conceivably wider, the entrance at the opposite side would still be wide enough to allow T 4 with its dimensions of 6ϫ12 Å to enter and would directly be restricted by the additional carbohydrate group in TBG-mD.
Binding of T 4 by TBG depends on the presence of its iodines, especially at the 5Ј-position (13) . It has been speculated that these might interact with the aromatic, rather than just hydrophobic, interior of the binding site, namely phenylalanine, and possibly also tyrosine residues (22 (Table  1) . This residue is located in the middle of strand 3B and thus in close spatial proximity to mutation mD, as shown in the model of the interior of the ligandbinding site (Fig. 7) .
In conclusion, mutations mD and mF249 locate the binding site deep within the ␤-barrel of TBG. A more precise structural analysis of T 4 binding awaits crystallization of TBG, attempts at which have now been intensified.
MATERIALS AND METHODS
Site-Directed Mutagenesis
The cDNA of normal TBG (TBG-N) had been subcloned previously into the pSELECT expression vector (33) . Sitedirected mutagenesis (Altered Sites Kit, Promega Corp., Madison, WI) with oligonucleotides (see Table 2 ) was performed to obtain vectors coding for the TBG mutants mA-mH and the F3A variants (mF249, mF284, mF288, mF315, and mF371). The coding regions of all TBG mutants were sequenced in its entirety by the dideoxy-nucleotide termination method (34) using the Sequenase-2 kit from United States Biochemical Corp. (Cleveland, OH). 
In Vitro Transcription
sRNA was prepared with the Gemini-II in vitro transcription kit and T7 RNA polymerase according to the recommendations of the supplier (Promega Corp.).
Cell-Free Translation
Translations were carried out in rabbit reticulocyte lysate in a final volume of 50 l according to the protocol supplied by the manufacturer (Promega Corp.). Samples were metabolically labeled with [ 
Preparation of Oocytes and RNA Injection
Ovaries were removed from mature Xenopus laevis (H. Kö hler, Hamburg, Germany) (35) and suspended in OR-IIa medium (83 mM NaCl, 2.5 mM KCl, 1 mM MgCl 2 , 1 mM Na 2 HPO 4 , and 5 mM HEPES, pH 7.6) (36). After manual dissection of the follicles, oocytes were dissociated from the surrounding connective tissue by incubation in OR-IIa containing 0.2% collagenase type IA (Sigma Chemical Co., St. Louis, MO) for 2 h with shaking at room temperature. The liberated oocytes were then rinsed extensively in OR-IIb medium (OR-IIa with 1 mM CaCl 2 and 100 mg/ml gentamycin), and stage VI oocytes (37) were separated and kept up to 3 days in OR-IIb with daily medium changes. After injection with 100 nl of sRNA (0.5 mg/ml), oocytes were kept on ice for 1 h and then for 2-6 h at 19 C in OR-IIb. Intact oocytes (routinely Ͼ95%) were transferred to 24-well plates (Costar) and kept in OR-IIc (OR-IIb with 1 mM sodium pyruvate), 5 l/oocyte, at 19 C for up to 4 days, with daily exchange of medium. Typically, 100 oocytes were injected with each sRNA preparation. Control oocytes were either injected with water or noninjected, with identical results. In some experiments, proteins synthesized by the oocytes were metabolically labeled by addition of 250 mCi [
35 S]methionine per 500 l medium.
SDS-Gel Electrophoresis
Products of cell-free translation or proteins synthesized in Xenopus oocytes were analyzed by the method of Laemmli (38), using 10% polyacrylamide gels. Gels were dried and autoradiographed at Ϫ90 C on X-AR5 film (Eastman Kodak Co.) with an intensifying screen.
Measurement of T 4 Binding to TBG
Parameters of T 4 -binding to TBG were measured by a method previously described in detail (39). Briefly, TBG preparations were incubated with [
125 I]T 4 (DuPont-NEN) in the presence of increasing amounts of unlabeled T 4 . TBG-bound T 4 was separated from free T 4 with anion exchange resin beads (Mallinckrodt, Inc., St. Louis, MO) and the proteinbound [
125 I] activity was determined. The affinity constants (K a ) of TBG preparations were determined by the method of Scatchard (40).
Immunoprecipitation
Immunoprecipitation was performed according to Kessler (41), with minor modifications as described (33) . The polyclonal antibodies used in this study (against both nTBG and dnTBG and against dnTBG only) have been described (42).
Heat Denaturation
The functional stability of the TBG variants was quantified by thermal denaturation in a water bath at 58 Ϯ 0.1 C for various periods of time. The samples were then cooled on ice and centrifuged for 15 min at 13,000 ϫ g to remove precipitated protein. Residual specific T 4 binding capacity was expressed relative to controls kept at 4 C. The half-lives (t 1/2 ) of heat denaturation were calculated by least square analysis of semilogarithmic plots of remaining specific T 4 binding vs. time of incubation.
Experimental Animals
All animal studies were conducted in accord with the principles and procedures outlined in the "Guidelines for Care and Use of Experimental Animals." 
